PRE 14A

SCHEDULE 14A

Company: PharmaCyte Biotech, Inc.
Filed: November 15, 2022
Period of Report: December 28, 2022
Accession Number: 0001683168-22-007786

View Document ↗ View on SEC.gov ↗